ClinicalTrials.Veeva

Menu

Cardiac Magnetic Resonance Predictors of Outcome of Rhythm Control in Patients with Atrial Fibrillation/Flutter

A

Assiut University

Status

Not yet enrolling

Conditions

Rhythm Monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT06758895
CMR in rythm control

Details and patient eligibility

About

evaluate the impact of various features in CMR on the mid-term/long-term success rate of rhythm control for paroxysmal atrial fibrillation/flutter .

Full description

  • Atrial fibrillation/flutter are widely prevalent.
  • Reported antiarrhythmic drug efficacy to restore & maintain sinus rhythm is 52% which is far from optimal.
  • On the other hand, 5-year arrhythmia-free survival after catheter ablation was previously reported to be 63%.
  • Therefore, there is a need for better characterization of the underlying atrial substrate, to improve treatment outcomes in terms of efficacy and safety

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>18 years.
  • Patients undergoing successful cardioversion (pharmacologic or electric) for atrial fibrillation/flutter, OR symptomatic patients with paroxysmal atrial fibrillation/flutter scheduled for trans-catheter ablation.
  • Index cardioversion OR Index ablation procedure.

Exclusion criteria

  • LA thrombus on TEE or CMR.
  • Contraindications to CMR.
  • Contraindications to Gd-based contrast.

Trial contacts and locations

1

Loading...

Central trial contact

Maryem Ashraf Abd El-Naeem Sayed, Resident Doctor; Amr EL-Badry Ibrahim, Lecture of cardiology

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems